Literature DB >> 33428216

Treatment-resistant tinea corporis, a potential public health issue.

E Chen1, M Ghannoum2, B E Elewski1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 33428216     DOI： 10.1111/bjd.19420

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses.

Authors:  Aditya K Gupta; Helen J Renaud; Emma M Quinlan; Neil H Shear; Vincent Piguet
Journal:  Am J Clin Dermatol       Date:  2020-12-22       Impact factor: 7.403

2.  Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial.

Authors:  Ananta Khurana; Aastha Agarwal; Diksha Agrawal; Sanjeet Panesar; Manik Ghadlinge; Kabir Sardana; Khushboo Sethia; Shalini Malhotra; Ankit Chauhan; Nirmala Mehta
Journal:  JAMA Dermatol       Date:  2022-09-14       Impact factor: 11.816

3.  A Case of Terbinafine-Resistant Tinea Cruris Caused by Trichophyton tonsurans.

Authors:  Alireza Firooz; Ensieh Lotfali; Mahsa Fattahi; Maryam Fattahi; Akram Miramin Mohammadi; Mahshid Shahrzad Kavkani
Journal:  Case Rep Dermatol Med       Date:  2021-11-29

4.  Epidemiology of dermatomycoses and onychomycoses in Ireland (2001-2020): A single-institution review.

Authors:  James Powell; Emma Porter; Sinead Field; Nuala H O'Connell; Kieran Carty; Colum P Dunne
Journal:  Mycoses       Date:  2022-07       Impact factor: 4.931
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.